$1.68
-0.04-2.05%
Last update: 2:07 PM
15 minutes delayed
Salarius Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Salarius Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-09 | $-2.37 | $-53.60 | 95.6 % |
Mar 2024 | 2024-05-13 | $-3.28 | $-53.60 | 93.9 % |
Dec 2023 | 2024-03-22 | $-1.76 | $-8.08 | 78.2 % |
Sep 2023 | 2023-11-09 | $-5.20 | $-9.60 | 45.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2021 | 2022-03-10 | $0 | $430.00K | -100.0 % |
Sep 2021 | 2021-11-04 | $0 | $1.16M | -100.0 % |
Jun 2021 | 2021-08-05 | $571.39K | $1.28M | -55.4 % |
Mar 2021 | 2021-05-12 | $1.27M | $1.37M | -7.37 % |
Salarius Pharmaceuticals (SLRX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 9, 2024 for Q2.
The Actual EPS was $-2.37, which beat the estimate of $-53.60.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.